StockWatch
·

GUJARAT NARMADA VALLEY FERTILIZERS & CHEMICALS LTD. Q2 FY27 Results

GNFCQ2 FY27 Results
Filing
Result:Steady· Market: Crashed#Margin squeeze

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue2.8K23.9%40.9%
Total Income2.9K24.0%38.5%
Expenditure2.7K38.3%42.6%
PBT241.0042.1%4.8%
Net Profit194.0037.8%8.4%
OPM7.10%10.46pp2.30pp
NPM6.69%6.65pp1.85pp
EPS13.2037.8%8.4%
View full financials

Revenue grew sharply but EBITDA/net margins compressed hard both YoY (OPM 9.4%→7.1%, NPM 8.5%→6.7%) and QoQ, leaving adjusted PAT growth modest and low-quality despite the core Chemicals segment staying marginally profitable YoY.

GNFC · Q2 FY27 · THE VERDICT

Growth That Doesn't Reach the Bottom Line

Revenue surged 40.9% year-over-year, but profit grew just 8.4%—and actually fell 37.8% quarter-on-quarter. One-time benefits masked a deeper deterioration in chemical margins that management attributes to import competition and energy volatility.

06 Nov 2026 · 6 min read
Reported PAT

₹194 Cr

+8.4% YoY, -37.8% QoQ

One-time benefits

₹75 Cr

Energy norm, wage settlement, freight claims

Adjusted PAT (est.)

~₹119 Cr

-69% YoY from adjusted Q1

Where the profit came from—and where it actually went

On the surface, the numbers look manageable: revenue up 41% year-over-year, profit up 8%. But flip to the quarter-on-quarter lens and the story inverts entirely. Net profit crashed 38%, from ₹312 Cr in Q1 to ₹194 Cr in Q2. Operating margin compressed 360 basis points, from 10.6% to 7.1%. That's not cyclical seasonality—that's deterioration.

Management has a ready explanation: one-time benefits boosted Q2 by ₹75 Cr (energy norm revision ₹61 Cr, wage settlement and freight claims ₹33 Cr net, partially offset). Strip those out, and normalized profit falls to roughly ₹119 Cr. That's a 69% drop from Q1's adjusted ₹255 Cr in the chemical segment alone, even after accounting for one-time noise.

Net Profit, ₹ Cr
0116.48232.96349.44312Q1 Reported194Q2 Reported75One-timers119Q2 Adjusted
The ₹75 Cr in one-timers masks underlying margin deterioration. Adjusted PAT is the organic read.

Management's claims vs. what holds up

Grading the call's key assertions

QoQ profit decline is driven by product margin erosion & energy costs

Supported

Confirmed: OPM fell from 10.6% to 7.1%; chemical segment profit ₹177 Cr (down ₹78 Cr QoQ). WNA, TGU, AN Melt prices hit sharply.

₹75 Cr in one-time benefits; underlying profit is lower

Supported

Disclosed ₹75 Cr net one-timers. Chemical segment reported ₹177 Cr; Q1 was ₹255 Cr. Adjusted profit trajectory is downward.

Energy norm improvement (NCU 6.37 vs. 6.20) adds ₹61 Cr benefit

Supported

Confirmed in subsidy receivable and P&L. Passed through as concession rate revision.

Coal plant operational from July 25; full benefit to flow in H2

Partial

Generating steam from July 25, but power cheaper from grid so immediate benefit muted. Full benefit pending guaranteed test run this quarter.

YoY volume improvement across products despite QoQ dips

Supported

Ammonia 1,78,000 MT (Q2); TDI 8,700 MT (down 30% QoQ due to 30–35 day July shutdown); WNA 1,14,000 MT. Volumes resilient YoY.

The real story: chemical margins under siege

Energy and other input costs are the narrative du jour, but the granular story is worse: chemical realizations are eroding faster than energy norms can offset. Weak Nitric Acid (WNA), Technical Grade Urea (TGU), and Ammonium Nitrate Melt all saw prices fall sharply in Q2 despite volume resilience. Management's answer is blunt: import parity pricing. Chinese capacity additions (Wanhua's 360 kt TDI plant) are creating headroom for imports. GNFC's chemical segment, which carried ₹255 Cr in Q1, fell to ₹177 Cr—a 31% drop in one quarter.

The fertilizer side held up better, buoyed by government subsidy mechanisms and the energy norm improvement. But fertilizers alone cannot carry the company if chemicals deteriorate. And chemicals look structurally challenged: the TDI plant took a 30–35 day shutdown in July due to 'viability issues' (i.e., cash loss at then-current spreads), a tangible signal of margin stress. TDI recovered post-July but production was only 8,700 MT in Q2—well below normalized capacity.

Basically, these are competitive forces, okay, which have created these impacts on various chemicals. As you know, ma'am, except one or two products, we do our pricing based on import parity.

What changed on this call

New vs. Q1 call
  • Chemical segment margin pressure is now explicit (was implicit before)

  • TDI production disruption in July disclosed (no prior warning)

  • Energy norm benefit ₹61 Cr realized (as flagged; now accounted)

  • Coal plant operational from July 25 (on timeline; benefit muted near-term)

  • Capex execution mostly on track (one project 3-month delayed)

The bull-bear ledger

  • Long-term capex (₹1.5–1.8 Cr FY27) on track; new projects will add ₹1.2–1.5 Cr revenue mid-2027

  • Coal-based captive plant now live; will reduce grid dependency and lower power costs H2 onwards

  • Volume resilience across ammonia, WNA, AN Melt despite margin pressure (YoY growth solid)

  • Cash position strong (~₹3,900 Cr); no financial distress near-term

  • QoQ profit collapse (-37.8%) signals structural, not cyclical, margin pressure

  • Chemical realizations eroding; import competition intensifying (Chinese TDI adding 360 kt)

  • One-time benefits (₹75 Cr) won't repeat; normalized profit trajectory is downward

  • Management refrained from Q3/H2 guidance on margins, citing 'price sensitivity' (low visibility ahead)

  • Geopolitical uncertainty (war since Feb 2026) ongoing; no clarity on feed availability or costs

Risks, ranked by how much they should concern a holder

What can go wrong—and how much it matters

Chemical margin compression persists

High

Segment profit fell 31% QoQ; if realization erosion continues, chemical contribution could deteriorate further. No floor yet.

Energy cost volatility swings margins by ₹100+ Cr per quarter

High

OPM fell 360 bps QoQ; subsidy lags reality; no full hedging. Management acknowledged 'very sharp upturns' but can't predict.

Import competition from Chinese capacity additions

High

Wanhua TDI 360 kt, Indian imports rising. Pricing power erodes. Import parity is a ceiling, not a floor.

TDI production disruptions recur

Medium

July shutdown due to cash loss at spreads shows fragility. If spreads compress again, plant could shut. Volume loss or write-down risk.

Capex execution delays cascade

Medium

One project already 3-month late. Geopolitical uncertainty adds risk. ₹1.5–1.8 Cr commitment is material to story.

Subsidy mechanism changes adversely

Medium

NITI Aayog reviewing urea cost structure. Subsidy rates lag energy norms. Policy shift could hurt fertilizer margins.

Street positioning: what the market is doing

The market's reaction has been unforgiving: the stock fell 8.99% on day 1 post-result and 9.9% by day 3, landing at ₹460.4. That move is reasonable. The result delivered disappointing margins and one-timers that don't repeat. RSI is now 27.9 (oversold), suggesting some capitulation, but the price action holds: GNFC is trading 26% off its 52-week low and 45% below its all-time high, a significant drawdown.

Valuation context: the stock is trading below its 20-day, 50-day, and 200-day moving averages—a clear technical break. Institutionally, FII holdings ticked up 1.06pp to 13.11% (DII flat at 11.02%, promoter stable at 41.30%), suggesting that some foreign investors are nibbling on the dip. But ownership hasn't surged, which implies even bulls are cautious.

The disconnect is telling: the market correctly punished the earnings miss and margin collapse, but hasn't turned it into a true capitulation or a deep-value play yet. That suggests consensus is 'wait and see' on Q3—will chemicals stabilize, will capex deliver, will energy costs ease? The oversold RSI offers a tactical bounce risk, but conviction is low.

What to watch next

The three data points that resolve the debate
  • 1 · Q3 chemical realizations

    Did WNA, TGU, and AN Melt stabilize or continue falling? If realizations hold steady with volume, the margin narrative improves. If they roll over further, structural deterioration is confirmed. This is the single most important metric.

  • 2 · Coal plant power cost benefit realization in H2

    How much cheaper is in-house power vs. grid? Management flagged the benefit will 'flow in H2'—track the P&L lift and capex trajectory. If this is material (even ₹20–30 Cr), it's a near-term upside surprise.

  • 3 · Capex delivery and new project revenue ramp

    One project is 3 months late; watch for further delays or completion updates. New projects are meant to add ₹1.2–1.5 Cr revenue by mid-2027. Execution on this timeline will validate the bull thesis. Slippage invalidates it.

GNFC delivered a quarter that looks better on the headline (revenue +41%) than it is (profit +8%, and adjusted profit down sharply). The margin collapse is real, the one-timers won't repeat, and chemical realizations are under siege. Management is executing on capex, and the coal plant is live, but those are long-term anchors in a sea of near-term uncertainty.

The stock at ₹460.4 is cheap on a historical basis and oversold technically, but that's not an all-clear—it's a reasonable valuation for a company in transition with murky near-term visibility. The next quarter will tell you if chemical margins stabilize or continue rolling over. Until then, this is a Hold. For bulls, the 12-month upside is real (capex + coal plant); for bears, the next two quarters are a margin minefield.

The single number to track from here: chemical segment profit in Q3 FY27. If it holds above ₹190 Cr (better than Q2's ₹177 Cr), the narrative is stabilization. If it dips below ₹160 Cr, structural deterioration is in play.

Informational and educational content only. Not investment advice.